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Abstract
Endothelial cells are important in the pathogenesis of bloodstream infections caused by Candida albicans and
Staphylococcus aureus. Numerous investigations have used human umbilical vein endothelial cells (HUVECs) to study
microbial-endothelial cell interactions in vitro. However, the use of HUVECs requires a constant supply of umbilical cords,
and there are significant donor-to-donor variations in these endothelial cells. The use of an immortalized endothelial cell line
would obviate such difficulties. One candidate in this regard is HMEC-1, an immortalized human dermal microvascular
endothelial cell line. To determine if HMEC-1 cells are suitable for studying the interactions of C. albicans and S. aureus with
endothelial cells in vitro, we compared the interactions of these organisms with HMEC-1 cells and HUVECs. We found that
wild-type C. albicans had significantly reduced adherence to and invasion of HMEC-1 cells as compared to HUVECs.
Although wild-type S. aureus adhered to and invaded HMEC-1 cells similarly to HUVECs, an agr mutant strain had
significantly reduced invasion of HMEC-1 cells, but not HUVECs. Furthermore, HMEC-1 cells were less susceptible to damage
induced by C. albicans, but more susceptible to damage caused by S. aureus. In addition, HMEC-1 cells secreted very little IL-
8 in response to infection with either organism, whereas infection of HUVECs induced substantial IL-8 secretion. This weak
IL-8 response was likely due to the anatomic site from which HMEC-1 cells were obtained because infection of primary
human dermal microvascular endothelial cells with C. albicans and S. aureus also induced little increase in IL-8 production
above basal levels. Thus, C. albicans and S. aureus interact with HMEC-1 cells in a substantially different manner than with
HUVECs, and data obtained with one type of endothelial cell cannot necessarily be extrapolated to other types.
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Introduction
Endothelial cells play a crucial role in the pathogenesis of many
types of human infections [1,2]. For example, after a microbial
pathogen enters the circulation, it must adhere to and invade the
endothelial cell lining of the blood vessels to infect deeper tissues to
cause organ dissemination. In addition, by expressing pro-
inflammatory cytokines and leukocyte adhesion molecules, endo-
thelial cells recruit phagocytes to foci of infection and are therefore
essential for orchestrating the host defense against microbial
pathogens.
Because of the importance of endothelial cells in the pathogen-
esis of bloodstream infections, numerous investigators have used in
vitro models of microbial-endothelial cell interactions to study the
mechanisms by which distinct microbial pathogens adhere to,
invade, damage, and activate endothelial cells. Many of these
investigations have used human umbilical vein endothelial cells
(HUVECs) [3–15]. For example, mutants of Candida albicans with
reduced capacity to damage HUVECs in vitro are likely to have
attenuated virulence in a murine model of hematogenously
disseminated candidiasis [13]. Also, the capacity of clinical isolates
of Staphylococcus aureus to damage HUVECs is directly correlated
with their virulence in the rabbit model of infective endocarditis,
and inversely correlated with their response to vancomycin in this
animal model [14]. Thus, these investigations demonstrate that
HUVECs may serve as a useful in vitro model of host-pathogen
interaction.
There are some disadvantages to using HUVECs for such
studies. Firstly, because they are primary cells, they exhibit
significant donor-to-donor variability in some microbial interac-
tions [16]. Secondly, they have a relatively short life span in vitro,
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and their phenotype can change with successive passages. Thirdly,
HUVECs can be difficult to transfect, and their finite life span
makes it problematic to develop stably transfected cell lines.
Finally, the availability of HUVECs may be constrained by
medical and ethical issues.
To overcome these problems, immortalized endothelial cell
lines have been developed. These cell lines have the advantages of
easier maintenance, longer life span, less variability, and better
availability. However, immortalization may lead to functional
defects, such as altered expression of leukocyte adhesion molecules
[17,18]. In addition, endothelial cells from different vascular beds
have a diversity of phenotypes in terms of their cell morphology,
function, gene expression, and antigen composition (Reviewed in
[19,20]). Thus, endothelial cells from different anatomic sites may
exhibit marked differences in their interactions with microbial
pathogens.
One immortalized cell line that has been used in studies of
microbial pathogenicity is the HMEC-1 cell line. This cell line was
developed by transfecting dermal human microvascular endothe-
lial cells from human foreskin with a plasmid containing the simian
virus 40A gene [21]. These cells have been used to study the
endothelial cell interactions of multiple microorganisms, including
Chlamydia pneumoniae [22], Brucella spp. [23], Bartonella henselae [24],
Mycobacterium tuberculosis [25], Orientia (Rickettsia) tsutsugamushi [26],
Rickettsia rickettsii [27], Candida albicans [28,29], and Staphylococcus
aureus [30].
In order to evaluate the usefulness of HMEC-1 cells for studying
different aspects of endovascular infection, we compared the
interactions of C. albicans and S. aureus with these cells and
HUVECs. We discovered that C. albicans and S. aureus interacted
with HMEC-1 cells in a significantly different manner as
compared to HUVECs.
Results
C. albicans, but Not S. aureus, has Reduced Adherence to
and Invasion of HMEC-1 Cells
We first compared the capacity of C. albicans and S. aureus to
adhere to and invade HMEC-1 cells and HUVECs. Because C.
albicans invades and damages endothelial cells much more rapidly
than does S. aureus [6,9,10,12,14,15,31,32], the C. albicans-
endothelial cell interactions were assessed at earlier time points
than the S. aureus-endothelial cell interactions. We found that wild-
type C. albicans cells had 23% lower adherence and 47% less
invasion of HMEC-1 cells compared to HUVECs (p,0.05 and
p,0.001 for adherence and invasion, respectively) (Fig. 1A). In
contrast, a wild-type strain of S. aureus adhered to and invaded
HMEC-1 cells similarly to HUVECs (Fig. 1B).
Next, we investigated whether microbial adherence to and
invasion of HMEC-1 cells and HUVECs occur via the same
mechanism(s). C. albicans Ssa1 and Als3 are invasin proteins that
are necessary for maximal endothelial cell adherence and invasion
(Table 1, [12,15]). We found that ssa1D/D and als3D/D mutant
strains were defective in their capacity to adhere to and invade
both HMEC-1 cells and HUVECs (Table 2). The magnitude of
these defects was similar for both HUVECs and HMEC-1 cells,
indicating that Ssa1 and Als3 mediate adherence to and invasion
of both types of endothelial cells.
We also evaluated the adherence and invasion of two S. aureus
mutants. One strain was JB-1, a stable gentamicin-induced small-
colony variant (SCV) of the clinical parental strain, 6850
(Table 1). SCV strains are known to persist within endothelial
cells, while causing little damage [14,33,34]. The second strain was
an agr deletion mutant of clinical MRSA isolate 300-169 (Table 1,
[14,35]). agr, the accessory gene regulatory locus of S. aureus
governs the expression of many adhesins and secreted virulence
factors, such as proteases and toxins, and is known to affect host
cell binding and invasion [14,32,34]. We found that while the
SCV mutant adhered to HMEC-1 cells similarly to its wild-type
parent strain, it had slightly decreased adherence to HUVECs
(Table 2). Also the SCV strain had increased capacity to invade
both types of endothelial cells as compared to parental strain, 6850
(Table 2). Although the adherence of the agr mutant to HMEC-1
cells and HUVECs was similar to that of its wild-type parental
strain, this mutant was defective in invading HMEC-1 cells, but
not HUVECs (Table 2). There was a non-significant trend
(p=0.06) towards reduced invasion of HMEC-1 cells compared to
HUVECs by the agr mutant, suggesting that agr may be required
for S. aureus to maximally invade HMEC-1 cells, but not
HUVECs.
HMEC-1 Cells and HUVECs Differ in their Susceptibility to
Damage Caused by C. albicans and S. aureus
The susceptibility of HMEC-1 cells and HUVECs to damage
induced by C. albicans was determined by a 51Cr release assay. We
found that HMEC-1 cells were significantly less susceptible than
HUVECs to damage caused by the wild-type strain. For example,
at the lowest multiplicity of infection (MOI), C. albicans induced
50% less damage to HMEC-1 cells as compared to HUVECs
(Fig. 2A). Furthermore, both the ssa1D/D and als3D/D mutants
caused significantly less damage to HMEC-1 cells than to
HUVECs (Table 3). This reduction in damage was due to
Figure 1. Adherence to and invasion of human umbilical vein endothelial cells (HUVECs) vs. HMEC-1 cells by wild-type C. albicans
and S. aureus. Adherence and endocytosis of C. albicans strain CAI4+CIp10 was assessed 1.5 h after infection at a MOI of 1 (A). Adherence and
endocytosis of S. aureus strain 6850 was determined 3 h after infection at a MOI of 1 (B). *, p,0.05 and ***, p,0.001 in HMEC-1 vs. HUVECs.
doi:10.1371/journal.pone.0039633.g001
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deletion of ALS3 and SSA1 because integrating an intact copy of
these genes into the respective deletion mutants restored their
capacity to damage both types of endothelial cells. Interestingly,
both the als3D/D and ssa1D/D mutants had significantly greater
damage defects on HMEC-1 cells than on HUVECs. Collectively,
these results indicate that HMEC-1 cells are more resistant to C.
albicans-induced damage than HUVECs. In addition, the presence
of Ssa1 and Als3 on the surface of C. albicans is more important for
damage of HMEC-1 cells than HUVECs.
In contrast to C. albicans, wild-type S. aureus caused significantly
more damage to HMEC-1 cells than to HUVECs (Fig. 2B). As
expected [14], the SCV and agr mutant strains had reduced
capacity to damage both endothelial cell types (Table 3).
However, the SCV strain caused significantly greater damage to
HMEC-1 cells than to HUVECs, whereas the agr mutant caused
greater damage to HUVECs than to HMEC-1 cells. Therefore,
the mechanisms by which S. aureus damages HMEC-1 cells and
HUVECs are likely to be different.
HMEC-1 Cells Secreted Little IL-8 in Response to C.
albicans and S. aureus Infection
The proinflammatory chemokine, IL-8, plays a key role in
activating and recruiting neutrophils and monocytes to sites of
infection [36]. We therefore compared the secretion of IL-8 by
HMEC-1 cells vs. HUVECs in response to microbial infection.
Table 1. C. albicans and S. aureus strains used in this study.
Strain Description Reference
C. albicans strains
DAY185 ura3D::limm434 ARG4::URA3::arg4::hisG his1::hisG::pHIS1
ura3D::limm434 arg4::hisG his1::hisG
[54]
CAI4+CIp10 URA3::ura3D::limm434 rps10D::pCIP10
ura3D::limm434 RPS10
[55]
ssa1D/D-URA3 ura3D::limm434 ssa1::FRT ssa2::FRT rps10::URA3
ura3D::limm434 ssa1::FRT SSA2 RPS10
[15]
ssa1D/SSA1 ura3D::limm434 ssa1::FRT ssa2::FRT rps10::URA3::SSA1
ura3D::limm434 ssa1::FRT SSA2 RPS10
[15]
CAYF178U ura3D::limm434::URA3-IRO1 als3::ARG4 arg4::hisG his1::hisG
ura3D::limm434 als3::HIS1 arg4::hisG his1::hisG
[12]
CAQTP178U ura3D::limm434::URA3-IRO1 als3::ARG4::ALS3 arg4::hisG his1::hisG
ura3D::limm434 als3::HIS1 arg4::hisG his1::hisG
[12]
S. aureus strains
6850 Wild type clinical osteomyelitis isolate, MSSA [33]
JB-1 Menadione auxotroph SCV from strain 6850 [33]
300-169 Clinical blood MRSA isolate, agr-I, SCCmec IV, CC45 [35]
300-169Dagr 300-169 agr::tet(M), Tcr [35]
Tcr, tetracycline-resistant.
doi:10.1371/journal.pone.0039633.t001
Table 2. Interactions of different C. albicans and S. aureus mutants with HUVECs and HMEC-1 cellsa.
HUVEC HMEC-1 p
Strain Interaction (% 6 SD of corresponding parental strain) (HUVEC vs. HMEC-1)
C. albicansb
ssa1D/D Adherence 66.4623.1** 71.3629.2* 0.697
Endocytosis 45.3629.7*** 44.6627.0** 0.183
als3D/D Adherence 52.669.5*** 44.9618.6*** 0.288
Endocytosis 4.062.6*** 2.661.1*** 0.958
S. aureusc
6850 JB-1 (SCV) Adherence 88.365.2** 96.265.7 ,0.05
Endocytosis 212.5696.5* 202.6699.5 0.887
300-169agrD Adherence 99.861.4 100.260.7 0.887
Endocytosis 92.0617.3 68.5617.9** 0.061
a, Data are expressed as % of the corresponding parental strain (set as 100%).
b, C. albicans binding was tested after 1.5 h at an MOI of 1.
c, S. aureus binding was tested after 3 h at an MOI of 1 and expressed as % of the total number of bacteria per well.
*, p,0.05; **, p,0.01 and ***, p,0.001 vs. corresponding parental strain. Endothelial cell adherence/endocytosis of parental strain was set as 100%.
doi:10.1371/journal.pone.0039633.t002
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After 6 h, uninfected HMEC-1 cells secreted approximately 10-
fold less IL-8 than did HUVECs (Fig. 3A). Furthermore, when
HMEC-1 cells were infected with wild-type C. albicans, secretion of
IL-8 increased by a maximum of only 1.8-fold (p=0.138). In
contrast, infection of HUVECs with wild-type C. albicans resulted
in up to a 5-fold increase in IL-8 secretion, depending on the MOI
(p,0.05 for all MOIs tested). Thus, IL-8 secretion by HMEC-1
cells is poorly responsive to C. albicans infection.
HMEC-1 cells also responded weakly to S. aureus. During the
24 h incubation period, the basal release of IL-8 in the absence of
infection was similar for HMEC-1 cells and HUVECs (Fig. 3B).
Infection of HMEC-1 cells with S. aureus stimulated only a slight
increase in IL-8 secretion at all MOIs tested. For instance,
maximal increase in IL-8 secretion occurred at an MOI of 5,
which resulted in only a 1.5-fold induction compared to uninfected
control HMEC-1. In contrast, IL-8 production by HUVECs was
highly inoculum-dependent. While the lowest inoculum tested
(MOI of 0.5) did not induce a significant increase in IL-8 secretion,
infection at MOIs of 5 and 50 led to a 4-fold and 2.3-fold increase
in IL-8 secretion, respectively. At the highest MOI tested (500)
there was no detectable increase in IL-8 secretion, probably
because most endothelial cells were killed by this high inoculum.
Collectively, these results indicate that HMEC-1 cells produce
very little IL-8 in response to infection with either C. albicans or S.
aureus, whereas IL-8 secretion by HUVECs is strongly induced by
both organisms.
To investigate whether the low IL-8 production by the HMEC-
1 cells was due to the anatomic source of these endothelial cells or
their viral transformation, we analyzed the IL-8 response of
primary human dermal microvascular endothelial cells
(HDMECs). The basal release of IL-8 by these endothelial cells
was significantly greater than that of both HUVECs and HMEC-1
cells after 6 h (Fig. 3). However, infection with three different
inocula of C. albicans did not induce a significant increase in IL-8
production by HDMECs (Fig. 3A), and S. aureus induced only
a 1.6-fold increase in IL-8 production at an MOI of 0.5 (Fig. 3B).
Therefore, although the low basal production of IL-8 by HMEC-1
cells is likely the result of their transformation, the minimal
increase in IL-8 production in response to C. albicans and S. aureus
infection is probably due to the anatomic source of these
endothelial cells.
Discussion
Although both HUVECs and HMEC-1 cells have been used to
investigate the interactions of microbial pathogens with endothelial
cells in vitro, there have been relatively few studies that directly
compared the response of these two types of endothelial cells to
Figure 2. Microbial induced damage to HUVECs and HMEC-1 cells. The extent of damage to the indicated endothelial cells was determined
by a 51Cr release assay, and was measured after 6 h of infection with C. albicans CAI4+CIp10 (A) and after 24 h of infection with S. aureus 6850 (B). **,
p,0.01 and ***, p,0.001 in HMEC-1 vs. HUVECs.
doi:10.1371/journal.pone.0039633.g002
Table 3. Capacity of different C. albicans and S. aureus mutants to damage HUVECs and HMEC-1 cells.
HUVEC HMEC-1 p
Strain (% 6 SD of the corresponding parental strain) (HUVEC vs. HMEC-1)
C. albicansa
ssa1D/D 74.769.4*** 38.1612.8*** ,0.0001
ssa1D/D+SSA1 103.369.1 104.0616.8 0.922
als3D/D 36.766.8*** 5.865.1*** ,0.0001
als3D/D+ALS3 101.763.7 100.165.2 0.448
S. aureusb
6850 JB-1 (SCV) 5.264.6*** 14.166.7*** ,0.0001
300-169Dagr 76.369.7*** 26.663.7*** ,0.0001
a, C. albicans induced damage was tested after 6 h at a MOI of 2.5.
b, S. aureus induced damage was tested after 24 h at a MOI of 50.
***, p,0.001 vs. corresponding parental strain. Endothelial cell damage of parental strain was set to 100%.
doi:10.1371/journal.pone.0039633.t003
Microbial-Endothelial Cell Interactions
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infection by prototypical endovascular pathogens. We determined
that C. albicans and S. aureus interacted significantly differently with
HMEC-1 cells as compared to HUVECs. For example, wild-type
C. albicans was less adherent to HMEC-1 cells than to HUVECs.
Furthermore, although we found that the als3D/D and ssa1D/D
mutants had reduced adherence to both types of endothelial cells
when tested under static conditions, it remains possible that C.
albicans adheres by different mechanisms to HMEC-1 cells than to
HUVECs under flow conditions. For instance, one group reported
that C. albicans hyphae are less adherent than yeast to HMEC-1
cells under flow conditions [29], whereas another group found that
C. albicans hyphae have greater adherence to HUVECs than do
yeast-phase organisms under conditions of flow [37]. Collectively,
these results suggest that the endothelial cells receptors that are
bound by C. albicans may differ in either their expression level or
composition between HMEC-1 cells and HUVECs.
We also found that C. albicans hyphae were endocytosed less
avidly by HMEC-1 cells than by HUVECs. It is known that C.
albicans hyphae induce their own endocytosis by binding to N-
cadherin on the surface of endothelial cells [38]. Although both
HUVECs and HMEC-1 cells express N-cadherin [38], it is
possible that the binding of C. albicans to N-cadherin may activate
divergent signaling pathways in these two types of cells.
Alternatively, receptors other than N-cadherin, which also mediate
the endocytosis of C. albicans might be expressed at higher level by
HUVECs than by HMEC-1 cells.
In addition, we determined that wild-type S. aureus cells were
endocytosed similarly by HUVECs and HMEC-1 cells, whereas
an SCV strain had markedly enhanced invasion of both
endothelial cell types as compared to its parental isolate. SCV
strains have previously been reported to have increased invasion of
HUVECs [14,34] and bovine aortic endothelial cells [39],
probably due to enhanced expression of fibronectin-binding
proteins, which are the essential mediators of S. aureus invasion
of host cells [40–42].
Interestingly, although an agr mutant had normal adherence to
both endothelial cell types as compared to its parental strain, it was
defective in invading HMEC-1 cells, but not HUVECs. The role
of agr in governing S. aureus adherence to endothelial cells is known
to be influenced by multiple factors, including the strain
background, growth phase, and whether adherence is measured
under static or flow conditions [43,44]. Thus, even though agr did
not affect endothelial cell adherence in our investigations, it might
have done so under different experimental conditions. In
concordance with our data, others have found that agr is
dispensable for S. aureus invasion of HUVECs [32]. However,
our finding that agr is necessary for maximal invasion of HMEC-1
cells again demonstrates that S. aureus interacts differently with this
endothelial cell line as compared to HUVECs.
As expected, C. albicans caused significant damage to HMEC-1
cells and HUVECs. However, we found that wild-type C. albicans
caused significantly less damage to HMEC-1 cells than to
HUVECs. Furthermore, damage to HMEC-1 cells was more
dependent on the presence of the C. albicans Ssa1 and Als3 invasins
than was damage to HUVECs. It is known that C. albicans must
invade endothelial cells to cause maximal damage to these cells
[6]. However the ssa1D/D and als3D/D mutant strains had similar
defects in their capacity to invade both HMEC-1 cells and
HUVECs. Thus, the differential susceptibility of HMEC-1 cells vs.
HUVECs to damage caused C. albicans might be due to differences
in post-invasion processes such as intracellular trafficking or
activation of signal transduction pathways.
In sharp contrast to C. albicans, S. aureus caused significantly
more damage to HMEC-1 cells as compared to HUVECs.
Because wild-type S. aureus cells were endocytosed similarly by
both types of endothelial cells, the differential susceptibility of
HMEC-1 cells and HUVECs to S. aureus-induced damage must
also be due to post- endothelial cell invasion events. Importantly,
the hyper-adherent SCV strain had the greatest damage defect on
HUVECs, whereas the agr mutant had the greatest damage defect
on HMEC-1 cells. Thus, the changes in S. aureus that occur during
SCV formation influence its ability to damage HUVECs more
than HMEC-1 cells. Conversely, factors controlled by agr (e.g.,
cytolytic toxins) mediate S. aureus-induced damage of HMEC-1
cells more than HUVECs.
We found that both C. albicans and S. aureus induced HUVECs
to secrete IL-8, as has been reported previously [8,45–47].
However, under the conditions tested, C. albicans did not stimulate
significant IL-8 production by HMEC-1 cells, while S. aureus
induced only a minor increase in IL-8 production by these
endothelial cells. Of note, HMEC-1 cells have been shown to
produce much lower levels of IL-8 than do HUVECs in response
to other stimuli, such as IL-1b and Brucella abortus [23,48].
Importantly, the production of additional proinflammatory and
proangiogenic factors such as IL-6, vascular cell adhesion
molecule-1, E-selectin, and vascular endothelial cell growth factor
is much lower in HMEC-1 cells as compared to HUVECs [17,18].
Figure 3. Endothelial cell stimulation. IL-8 levels in conditioned
media of HUVECs, HMEC-1 cells, and HDMECs were determined 6 h
after infection with C. albicans DAY185 (A) and 24 h after infection with
S. aureus 6850 (B). Ctrl, uninfected controls; *, p,0.05; **, p,0.01; and
***, p,0.001 in HMEC-1 or HDMEC vs. HUVECs; {, p,0.05; and {{{,
p,0.001 in conditioned media vs. uninfected controls.
doi:10.1371/journal.pone.0039633.g003
Microbial-Endothelial Cell Interactions
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39633
Our data with primary HDMECs suggest that while the low basal
production of IL-8 by the HMEC-1 cells may be due to their
transformation, the poor IL-8 production by these endothelial cells
in response to C. albicans and S. aureus may be a general property of
dermal microvascular endothelial cells. Nevertheless, these collec-
tive findings suggest that HUVECs are preferable to HMEC-1
cells for studying the effects of C. albicans and S. aureus on
stimulation of the endothelial cell proinflammatory response.
In summary, our current data indicate that C. albicans and S.
aureus interact with HMEC-1 cells significantly differently than
with HUVECs. Thus, data obtained with one type of endothelial
cell cannot necessarily be extrapolated to other types obtained
from different vascular beds. Furthermore, both primary and
transformed dermal microvascular endothelial cells release very
little IL-8 above basal levels in response to C. albicans or S. aureus
infection, in contrast to HUVECs. On the other hand, HMEC-1
cells may be particularly useful for investigating mechanisms of
endothelial cell damage that depend upon the C. albicans Ssa1 and
Als3 invasins or the target genes of the S. aureus agr regulon.
Moreover, a key consideration when deciding which type of
endothelial cell to use to investigate microbial-endothelial cell
interactions in vitro is how well these interactions are predictive of
the events that occur during in vivo infection. We have found
previously that the capacity of different strains of C. albicans and S.
aureus to damage HUVECs in vitro is directly correlated with their
virulence in animal models of hematogenous infection [13,14].
Whether one or more interactions of these microbial pathogens
with HMEC-1 cells is also predictive of virulence will be the focus
of future investigations.
Materials and Methods
Ethics Statement
The protocol for collecting umbilical cords for the harvesting of
HUVECs used in these studies was approved by the Institutional
Review Board of the Los Angeles Biomedical Research Institute at
Harbor-UCLA Medical Center. This protocol was granted
a waiver of consent because the donors remained anonymous.
Endothelial Cell Culture
HUVECs were harvested from human umbilical cord veins by
the method of Jaffe et al. [49], and maintained in complete M199
medium (with 10% fetal bovine serum and 10% bovine calf serum,
plus penicillin, 100 IU/ml; streptomycin, 100 mg/ml) as pre-
viously described [6]. HUVECs were routinely used at passage 3
for various assays. HMEC-1 cells were obtained from Kathryn
Kellar of the Centers for Disease Control (CDC), and maintained
as recommended [21]. HDMECs were purchased from Lonza
BioResearch and grown as directed. All experiments in which
HUVECs were compared with HMEC-1 cells were performed in
parallel.
Bacterial and Fungal Strains and Growth Conditions
We selected C. albicans and S. aureus for these investigations as
they represent two prototypical endovascular pathogens. All C.
albicans and S. aureus strains used in this study are listed in Table 1.
For use in the experiments, C. albicans yeast-phase cells were grown
in YPD (1% yeast extract, 2% Bacto-peptone, 2% D-glucose)
broth overnight in a rotary shaker at 30uC. All S. aureus strains
were grown overnight in Bacto BHI broth (Difco) without shaking
at 37uC. On the day of the experiment, the organisms were
harvested by centrifugation and washed with PBS. The C. albicans
cells were counted using a hemacytometer and the S. aureus cells
were adjusted to an OD600 of 0.5 and diluted accordingly. S. aureus
inocula were confirmed by quantitative culture. The construction
of the C. albicans ssa1D/D+SSA1 and als3D/D+ALS3 complemen-
ted strains was described previously [12,15]. Attempts to
genotypically and phenotypically complement the entire agr
operon in the 300-169Dagr mutant were unsuccessful, as has been
reported by others [50].
Adherence and Endocytosis Assays
The capacity of the various C. albicans strains to adhere to and
be endocytosed by HUVECs and HMEC-1 cells was quantified
using our previously described differential fluorescence assay [13].
Briefly, the endothelial cells were grown on 12-mm-diameter glass
cover slips and inoculated at a MOI of 1 in RPMI 1640 medium.
After 1.5 h, the nonadherent organisms were removed by rinsing
with Hanks balanced solution (HBSS), after which the cells were
fixed with 3% paraformaldehyde. The adherent, extracellular
organisms were stained with anti-C. albicans rabbit antiserum
(Biodesign International) conjugated with Alexa Fluor 568 (red
fluorescence; Molecular Probes). Next, the host cells were
permeabilized in 0.5% Triton X-100, after which the cell-
associated organisms (the adherent plus endocytosed organisms)
were stained with anti-C. albicans antiserum conjugated with Alexa
Fluor 488 (green fluorescence). For ease of discussion, organisms
that were host-cell associated are referred to as ‘‘adherent’’. The
cover slips were mounted inverted on a microscope slide, and the
number of endocytosed and cell-associated organisms was de-
termined by viewing the cells with an epifluorescent microscope.
At least 100 organisms were counted on each cover slip, and
organisms that were partially internalized were scored as being
endocytosed. Each experiment was carried out in triplicate on at
least three separate occasions.
The capacity of the various S. aureus strains to adhere to and be
endocytosed by endothelial cells was quantified using the
lysostaphin protection assay [51,52]. Briefly, endothelial cells were
grown to confluency and inoculated at a MOI of 1 in M199
invasion medium (M199 without antibiotics and serum, but with
1% human albumin, [14,32]). After 3 h, one half of wells were
washed three times with HBSS, after which the endothelial cells
were detached and then lysed. The number of host-cell associated
S. aureus was determined by quantitative culture. To determine the
number of internalized bacteria, complete M199 medium with
10 mg/ml lysostaphin was added to the endothelial cells. After
20 min incubation, the wells were rinsed three times and the
number of internalized bacteria was determined by lysing the host
cells with cold distilled water followed by quantitative culture.
Each strain was tested in duplicate in at least three different
experiments.
Endothelial Cell Damage Assay
The extent of endothelial cell damage caused by the different
strains of C. albicans was measured using our previously described
51Cr release assay [6]. Briefly, host cells were loaded with 6 mCi/
ml Na2
51CrO4 (MP Biomedicals) overnight. After removing the
unincorporated 51Cr by rinsing, the cells were infected with yeast
of the various C. albicans strains resuspended in RPMI 1640. The
infected host cells were incubated for 6 h, after which the amount
of 51Cr released into the medium and retained by the cells was
determined by c-counting. Wells containing host cells, but no
organisms, were processed in parallel to determine the spontane-
ous release of 51Cr.
The amount of endothelial cell damage induced by S. aureus was
also determined with a 51Cr release assay as previously described
[14]. Briefly, bacteria were added to the endothelial cells in
M199 invasion medium for 3 h, after which 500 ml of fresh
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complete M-199 medium containing 10 mg/ml lysostaphin was
added [51,53]. Damage was determined 24 h after infection at the
indicated MOIs. Each strain and condition was tested in triplicate
on at least three different occasions.
The optimal time for damage assay assessments for the two
different organisms was determined after extensive pilot studies.
Detection of IL-8 in Conditioned Media
The effects of C. albicans and S. aureus on endothelial cell
secretion of IL-8 were determined using the same inocula and
incubation conditions as in the damage experiments, except that
M-199 medium was used in both the C. albicans and S. aureus
experiments. At the end of the defined incubation period, the
conditioned medium above the endothelial cells was collected,
centrifuged at 1,000 g to pellet the cells, and then frozen in
aliquots at 280C for later analysis. The concentrations of IL-8 in
conditioned media were determined by commercial enzyme-
linked immunosorbent assays (Invitrogen) according to the
manufacturer’s instructions. Each strain and condition was tested
in duplicate in three independent experiments.
Statistical Analyses
The data were analyzed using the two-tailed student’s t-test, and
p-values #0.05 were considered statistically significant.
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